Compare
2 stocks, side by sideRelative performance · rebased to 100
EXELJAZZ
Pair ratio · EXEL ÷ JAZZRelative value, rich or cheap vs their own history
The price ratio EXEL ÷ JAZZ with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| EXELExelixis, Inc. | JAZZJazz Pharmaceuticals plc | |
|---|---|---|
| Smart Score | 8/10 | 6/10 |
| Price | $53.23 | $226.20 |
| 1 month | +6.5% | -4.7% |
| 1 year | +16% | +109% |
| 5 year | +141% | +27% |
| P/E (TTM) | 16.1 | 481.2 |
| P/E vs sector | -49% | +1427% |
| Market cap | $13.4B | $14.2B |
| Sector | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.